Theriva Biologics, Inc. Payments to Acquire Marketable Securities
Theriva Biologics, Inc. (TOVX) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-04-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2013-04-16
- Theriva Biologics, Inc. payments to acquire marketable securities for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. payments to acquire marketable securities for the quarter ending 2011-12-31 was $1.50M.
- Theriva Biologics, Inc. payments to acquire marketable securities for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Theriva Biologics, Inc. payments to acquire marketable securities for fiscal 2011 was $4.37M.
- Theriva Biologics, Inc. payments to acquire marketable securities for fiscal 2010 was $0.00.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-16 | $0.00 10-K · filed 2013-04-16 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 | ||
| 2011-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-16 | $4.37M 10-K · filed 2013-04-16 | |
| 2011-09-30 | $2.87M 10-Q · filed 2012-11-14 | ||
| 2010-12-31 | $0.00 10-K/A · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |